SHAREHOLDER ALERT: Morris Kandinov Investigating TSN, TVTY, LCID and INSD; Shareholders are Encouraged to Contact the Firm
December 22 2021 - 4:50PM
National law firm Morris Kandinov is investigating the actions of
the officers and board of directors of Tyson Foods, Inc., Tivity
Health, Inc., Lucid Group, Inc., and Instadose Pharma Corp. If you
are a current owner of shares of any of these stocks, contact
leo@moka.law or call (619) 780-3993.
Tyson Foods, Inc.
(NYSE: TSN)
Shareholder Rights Investigation
Morris Kandinov is investigating Tyson Foods,
Inc. regarding corporate governance failures, possible breaches of
fiduciary duties and other violations of law on behalf of
shareholders. U.S. District Judge Thomas Durkin granted approval to
three settlements totaling $93.5 million that commercial and
institutional indirect purchasers reached with Tyson Foods Inc.,
Pilgrim's Pride Corp. and Mar-Jac Poultry Inc. to settle claims
they conspired with competitors to fix the price of broiler
chicken. Under the deals, Tyson will pay $42.5 million of the
settlement. The U.S. Department of Justice also looked into
anti-competitive conduct in the broiler-chicken industry and
revealed its investigation in 2019. The DOJ's ongoing probe has
resulted in the indictment of several poultry executives, including
former Tyson Foods sales executive Timothy R. Mulrenin. To learn
more about this investigation and your rights,
visit: https://moka.law/case-contact-form/. Representation is
contingency based, no out of pocket costs.
Tivity Health, Inc.
(NASDAQ: TVTY) Accused of Misleading
Investors
Morris Kandinov reminds investors that on July
29, 2021, Judge Waverly Crenshaw, Jr. of the United States District
Court for the Middle District of Tennessee issued an order denying
in part the defendants’ motion to dismiss in the pending securities
class action against Tivity Health, Inc., paving the way for
litigation to proceed. Tivity provides fitness and wellness
programs geared toward senior citizens. According to the complaint,
defendants made false and misleading statements regarding Tivity’s
acquisition of Nutrisystem for $1.3 billion. On February 19, 2020,
Tivity announced its financial results for the fourth quarter and
year ended December 31, 2019, disclosing that its "Nutrition
segment had a disappointing end to 2019" including "a non-cash
impairment charge of $377.1 million," that contributed to a $272.8
million net loss in the fourth quarter, due to complications in the
nutrition business since its acquisition of Nutrisystem in March
2019. The company also announced that its Chief Executive Officer
had resigned. In September of 2020, the company announced the
resignation of co-founder Daniel G. Tully from its Board of
Directors. Then, in October of 2020, it was reported that the
company would be selling Nutrisystem for $575 million, less than
half of what Tivity paid to buy it. Morris Kandinov is
investigating Tivity regarding possible breaches of fiduciary
duties and other violations of law, including securities claims on
behalf of shareholders. To learn more about this investigation and
your rights, visit: https://moka.law/case-contact-form/.
Representation is contingency based, no out of pocket costs.
Lucid Group, Inc.
(NASDAQ: LCID)
Shareholder Rights Investigation
Morris Kandinov is investigating potential
claims against Lucid Group, Inc. regarding whether the Company has
violated the federal securities laws and/or engaged in other
unlawful business practices. On December 6, 2021, Lucid disclosed
in a filing with the U.S. Securities and Exchange Commission that
“[o]n December 3, 2021, [Lucid] received a subpoena from the [SEC]
requesting the production of certain documents related to an
investigation by the SEC. Although there is no assurance as to the
scope or outcome of this matter, the investigation appears to
concern the business combination between the Company (f/k/a
Churchill Capital Corp. IV) and Atieva, Inc. and certain
projections and statements.” On this news, Lucid’s stock price fell
sharply during intraday trading on December 6, 2021. To learn more
about this investigation and your rights,
visit: https://moka.law/case-contact-form/. Representation is
contingency based, no out of pocket costs.
Instadose Pharma
Corp. (OTC: INSD) Shareholder Rights
Investigation
Morris Kandinov is investigating potential
claims against Instadose Pharma Corp. The investigation concerns
whether Instadose has violated the federal securities laws and/or
engaged in other unlawful business practices. On November 23, 2021,
the U.S. Securities and Exchange Commission announced a temporary
suspension in the trading of Instadose securities due to concerns
regarding the adequacy and accuracy of information about the
Company in the marketplace. The SEC specifically noted stock price
and volume increases of Instadose stock unsupported by the
Company’s assets and financial information, trading that may be
associated with individuals related to a control person at the
Company, and operations at the Company’s Canadian affiliate. On
this news, the Company’s share price declined by $3.69 per share,
or approximately 13%, from $28.30 per share to close at $24.61 per
share on November 23, 2021, which was immediately before trading
was halted. On December 9, 2021, when the Company’s securities
resumed trading, the stock price opened and closed at $2.00 per
share. To learn more about this investigation and your rights,
visit: https://moka.law/case-contact-form/. Representation is
contingency based, no out of pocket costs.
Concerned shareholders are encouraged to contact
Leo Kandinov to learn more:
leo@moka.law (619) 780-3993moka.law
Morris Kandinov LLP is a national law firm that
specializes in recovering investment losses and protecting
stockholder rights. We work on contingency (i.e., you do not pay
our fees out-of-pocket), and our attorneys have made substantial
recoveries for investors in jurisdictions across the country. The
firm would be happy to further discuss these matters, and any legal
rights or remedies potentially available to you, at no charge.
Attorney Advertising. Past results do not
guarantee a similar outcome.
Contact:
Leo Kandinov, Partnerleo@moka.law619-780-3993550
West B Street, 4th FloorSan Diego, CA 92101moka.law
Lucid (NASDAQ:LCID)
Historical Stock Chart
From Aug 2024 to Sep 2024
Lucid (NASDAQ:LCID)
Historical Stock Chart
From Sep 2023 to Sep 2024